Jonathan Weissman, MIT

Ex­clu­sive: Big-name aca­d­e­mics and in­vestors are qui­et­ly prepar­ing a slate of new (epi)genome edit­ing com­pa­nies

A few weeks af­ter Jen­nifer Doud­na in­tro­duced CRISPR/Cas9 genome edit­ing to the world, one of her old stu­dents de­cid­ed to take the cen­tral part of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.